Dai Ichi Life Insurance Company, LTD Amgen Inc Transaction History

Dai Ichi Life Insurance Company, LTD

  • $4.06 Billion
  • Q2 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Amgen Inc stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 55,538 shares of AMGN stock, worth $17.6 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
55,538
Previous 90,244 38.46%
Holding current value
$17.6 Million
Previous $25.7 Million 32.37%
% of portfolio
0.43%
Previous 0.59%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$262.75 - $319.31 $9.12 Million - $11.1 Million
-34,706 Reduced 38.46%
55,538 $17.4 Million
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $2.61 Million - $3.15 Million
-9,713 Reduced 9.72%
90,244 $25.7 Million
Q4 2023

Feb 09, 2024
BUY
$255.7 - $288.46 $7.42 Million - $8.37 Million
28,999 Added 40.87%
99,957 $28.8 Million
Q3 2023

Nov 02, 2023
SELL
$218.65 - $271.46 $3.61 Million - $4.48 Million
-16,516 Reduced 18.88%
70,958 $19.1 Million
Q2 2023

Aug 11, 2023
SELL
$214.27 - $253.37 $95,778 - $113,256
-447 Reduced 0.51%
87,474 $19.4 Million
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $1.26 Million - $1.53 Million
5,569 Added 6.76%
87,921 $21.3 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $940,397 - $1.19 Million
-4,106 Reduced 4.75%
82,352 $21.6 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $678,093 - $764,766
-3,021 Reduced 3.38%
86,458 $19.5 Million
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $5.19 Million - $5.77 Million
-22,479 Reduced 20.08%
89,479 $21.8 Million
Q1 2022

May 13, 2022
SELL
$219.27 - $242.57 $221,901 - $245,480
-1,012 Reduced 0.9%
111,958 $27.1 Million
Q4 2021

Feb 11, 2022
SELL
$198.88 - $227.6 $3.2 Million - $3.66 Million
-16,097 Reduced 12.47%
112,970 $25.4 Million
Q3 2021

Nov 04, 2021
SELL
$212.27 - $248.7 $5.29 Million - $6.19 Million
-24,902 Reduced 16.17%
129,067 $27.4 Million
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $4.65 Million - $5.16 Million
19,899 Added 14.84%
153,969 $37.5 Million
Q1 2021

May 13, 2021
SELL
$221.91 - $258.6 $997,707 - $1.16 Million
-4,496 Reduced 3.24%
134,070 $33.4 Million
Q4 2020

Feb 11, 2021
BUY
$216.38 - $257.67 $10.7 Million - $12.7 Million
49,451 Added 55.49%
138,566 $31.9 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $4.59 Million - $5.1 Million
19,552 Added 28.11%
89,115 $22.6 Million
Q2 2020

Aug 12, 2020
BUY
$197.81 - $242.74 $1.19 Million - $1.46 Million
6,009 Added 9.45%
69,563 $16.4 Million
Q1 2020

May 08, 2020
SELL
$182.24 - $241.7 $117,727 - $156,138
-646 Reduced 1.01%
63,554 $12.9 Million
Q4 2019

Feb 13, 2020
BUY
$189.21 - $243.2 $897,990 - $1.15 Million
4,746 Added 7.98%
64,200 $15.5 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $2.05 Million - $2.46 Million
-11,776 Reduced 16.53%
59,454 $11.5 Million
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $7,001 - $8,207
-42 Reduced 0.06%
71,230 $13.1 Million
Q1 2019

May 14, 2019
SELL
$180.87 - $203.88 $116,299 - $131,094
-643 Reduced 0.89%
71,272 $13.5 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $1.28 Million - $1.49 Million
-7,178 Reduced 9.08%
71,915 $14 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $662,597 - $746,990
-3,576 Reduced 4.33%
79,093 $16.4 Million
Q2 2018

Aug 10, 2018
SELL
$166.05 - $186.51 $1.54 Million - $1.73 Million
-9,272 Reduced 10.08%
82,669 $15.3 Million
Q1 2018

May 15, 2018
SELL
$169.43 - $198.0 $114,195 - $133,452
-674 Reduced 0.73%
91,941 $15.7 Million
Q4 2017

Feb 13, 2018
SELL
$168.79 - $188.59 $468,223 - $523,148
-2,774 Reduced 2.91%
92,615 $16.1 Million
Q3 2017

Nov 09, 2017
BUY
$167.29 - $191.0 $16 Million - $18.2 Million
95,389
95,389 $17.8 Million

Others Institutions Holding AMGN

# of Institutions
3,073
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email